The observed dysfunction of intestinal barrier integrity, in conjunction with higher IEL counts (intraepithelial lymphocytes), elevated lysozyme protein and antimicrobial peptide expression in GSD patients strongly suggests that dysbiosis of gut microbiome contributes to GSD pathogenesis. The gene discussed is LYZ; the disease is disorder of glycogen metabolism.